1
|
Li X, Pan C, Ma W, Yang T, Wang C, Han W, Zhang W, Li H, Li Z, Zhao T, Guo XF, Li D. Effects of dietary supplementation of fish oil plus vitamin D 3 on gut microbiota and fecal metabolites, and their correlation with nonalcoholic fatty liver disease risk factors: a randomized controlled trial. Food Funct 2024; 15:2616-2627. [PMID: 38356413 DOI: 10.1039/d3fo02319b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2024]
Abstract
We previously reported that fish oil plus vitamin D3 (FO + D) could ameliorate nonalcoholic fatty liver disease (NAFLD). However, it is unclear whether the beneficial effects of FO + D on NAFLD are associated with gut microbiota and fecal metabolites. In this study, we investigated the effects of dietary supplementation of FO + D on gut microbiota and fecal metabolites and their correlation with NAFLD risk factors. Methods: A total of 61 subjects were randomly divided into three groups: FO + D group (2.34 g day-1 of eicosatetraenoic acid (EPA) + docosahexaenoic acid (DHA) + 1680 IU vitamin D3), FO group (2.34 g day-1 of EPA + DHA), and corn oil (CO) group (1.70 g d-1 linoleic acid). Blood and fecal samples were collected at the baseline and day 90. Gut microbiota were analyzed through 16S rRNA PCR analysis, and fecal co-metabolites were determined via untargeted ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). Results: The relative abundance of Eubacterium (p = 0.03) and Lactobacillus (p = 0.05) increased, whereas that of Streptococcus (p = 0.02) and Dialister (p = 0.04) decreased in the FO + D group compared with the CO group. Besides, changes in tetracosahexaenoic acid (THA, C24:6 n-3) (p = 0.03) levels were significantly enhanced, whereas 8,9-DiHETrE levels (p < 0.05) were reduced in the FO + D group compared with the CO group. The changes in 1,25-dihydroxyvitamin D3 levels in the fecal samples were inversely associated with insulin resistance, which was determined using the homeostatic model assessment model (HOMA-IR, r = -0.29, p = 0.02), and changes in 8,9-DiHETrE levels were positively associated with adiponectin levels (r = -0.43, p < 0.05). Conclusion: The present results indicate that the beneficial effects of FO + D on NAFLD may be partially attributed to the impact on gut microbiota and fecal metabolites.
Collapse
Affiliation(s)
- Xueqi Li
- Institute of Nutrition & Health, Qingdao University, Qingdao, China.
- School of Public Health, Qingdao University, Qingdao, China
- Binzhou Center for Disease Control and Prevention, Binzhou, China
| | - Chi Pan
- Institute of Nutrition & Health, Qingdao University, Qingdao, China.
- School of Public Health, Qingdao University, Qingdao, China
| | - Wenjun Ma
- Institute of Nutrition & Health, Qingdao University, Qingdao, China.
- School of Public Health, Qingdao University, Qingdao, China
| | - Ting Yang
- Institute of Nutrition & Health, Qingdao University, Qingdao, China.
- School of Public Health, Qingdao University, Qingdao, China
| | - Chong Wang
- Institute of Nutrition & Health, Qingdao University, Qingdao, China.
- School of Public Health, Qingdao University, Qingdao, China
| | - Weiwei Han
- Institute of Nutrition & Health, Qingdao University, Qingdao, China.
- School of Public Health, Qingdao University, Qingdao, China
| | - Wei Zhang
- Affiliated Hospital of Qingdao University, Qingdao, China
| | - Hui Li
- Affiliated Hospital of Qingdao University, Qingdao, China
| | - Zhongxia Li
- Byhealth Institute of Nutrition & Health, Guangzhou, China
| | - Ting Zhao
- Affiliated Hospital of Qingdao University, Qingdao, China
| | - Xiao-Fei Guo
- Institute of Nutrition & Health, Qingdao University, Qingdao, China.
- School of Public Health, Qingdao University, Qingdao, China
| | - Duo Li
- Institute of Nutrition & Health, Qingdao University, Qingdao, China.
- School of Public Health, Qingdao University, Qingdao, China
| |
Collapse
|
2
|
Production of C20 9S- and C22 11S-hydroxy fatty acids by cells expressing Shewanella hanedai arachidonate 9S-lipoxygenase. Appl Microbiol Biotechnol 2022; 107:247-260. [DOI: 10.1007/s00253-022-12285-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2022] [Revised: 10/24/2022] [Accepted: 11/08/2022] [Indexed: 11/29/2022]
|
3
|
Hofbauer TM, Distelmaier K, Muqaku B, Spinka G, Seidl V, Arfsten HT, Hagn G, Meier‐Menches S, Bartko PE, Pavo N, Hoke M, Prausmueller S, Heitzinger G, Pils D, Lang IM, Hengstenberg C, Hülsmann MP, Gerner C, Goliasch G. Metabolomics implicate eicosanoids in severe functional mitral regurgitation. ESC Heart Fail 2022; 10:311-321. [PMID: 36217578 PMCID: PMC9871691 DOI: 10.1002/ehf2.14160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2022] [Accepted: 09/08/2022] [Indexed: 01/27/2023] Open
Abstract
AIMS Secondary, or functional, mitral regurgitation (FMR) was recently recognized as a separate clinical entity, complicating heart failure with reduced ejection fraction (HFrEF) and entailing particularly poor outcome. Currently, there is a lack of targeted therapies for FMR due to the fact that pathomechanisms leading to FMR progression are incompletely understood. In this study, we sought to perform metabolomic profiling of HFrEF patients with severe FMR, comparing results to patients with no or mild FMR. METHODS AND RESULTS Targeted plasma metabolomics and untargeted eicosanoid analyses were performed in samples drawn from HFrEF patients (n = 80) on optimal guideline-directed medical therapy. Specifically, 17 eicosanoids and 188 metabolites were analysed. Forty-seven patients (58.8%) had severe FMR, and 33 patients (41.2%) had no or non-severe FMR. Comparison of eicosanoid levels between groups, accounting for age, body mass index, and sex, revealed significant up-regulation of six eicosanoids (11,12-EET, 13(R)-HODE, 12(S)-HETE, 8,9-DiHETrE, metPGJ2, and 20-HDoHE) in severe FMR patients. Metabolites did not differ significantly. In patients with severe FMR, but not in those without severe FMR, levels of 8,9-DiHETrE above a cut-off specified by receiver-operating characteristic analysis independently predicted all-cause mortality after a median follow-up of 43 [interquartile range 38, 48] months [hazard ratio 12.488 (95% confidence interval 3.835-40.666), P < 0.0001]. CONCLUSIONS We report the up-regulation of various eicosanoids in patients with severe FMR, with 8,9-DiHETrE appearing to predict mortality. Our observations may serve as a nucleus for further investigations into the causes and consequences of metabolic derangements in this important valvular abnormality.
Collapse
Affiliation(s)
- Thomas M. Hofbauer
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Klaus Distelmaier
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria,Herz Zentrum WaehringViennaAustria
| | - Besnik Muqaku
- Institute of Analytical ChemistryUniversity of ViennaViennaAustria
| | - Georg Spinka
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Veronika Seidl
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Henrike T. Arfsten
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Gerhard Hagn
- Institute of Analytical ChemistryUniversity of ViennaViennaAustria
| | - Samuel Meier‐Menches
- Institute of Analytical ChemistryUniversity of ViennaViennaAustria,Joint Metabolome FacilityUniversity of Vienna and Medical University of ViennaViennaAustria
| | - Philipp E. Bartko
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Noemi Pavo
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Matthias Hoke
- Department of Angiology, Internal Medicine IIMedical University of ViennaViennaAustria
| | - Suriya Prausmueller
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Gregor Heitzinger
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Dietmar Pils
- Joint Metabolome FacilityUniversity of Vienna and Medical University of ViennaViennaAustria
| | - Irene M. Lang
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Christian Hengstenberg
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Martin P. Hülsmann
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria
| | - Christopher Gerner
- Joint Metabolome FacilityUniversity of Vienna and Medical University of ViennaViennaAustria
| | - Georg Goliasch
- Department of Cardiology, Internal Medicine IIMedical University of ViennaWaehringer Guertel 18‐20A‐1090ViennaAustria,Herz Zentrum WaehringViennaAustria
| |
Collapse
|
4
|
Shinto LH, Raber J, Mishra A, Roese N, Silbert LC. A Review of Oxylipins in Alzheimer's Disease and Related Dementias (ADRD): Potential Therapeutic Targets for the Modulation of Vascular Tone and Inflammation. Metabolites 2022; 12:826. [PMID: 36144230 PMCID: PMC9501361 DOI: 10.3390/metabo12090826] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 08/24/2022] [Accepted: 08/29/2022] [Indexed: 12/01/2022] Open
Abstract
There is now a convincing body of evidence from observational studies that the majority of modifiable Alzheimer's disease and related dementia (ADRD) risk factors are vascular in nature. In addition, the co-existence of cerebrovascular disease with AD is more common than AD alone, and conditions resulting in brain ischemia likely promote detrimental effects of AD pathology. Oxylipins are a class of bioactive lipid mediators derived from the oxidation of long-chain polyunsaturated fatty acids (PUFAs) which act as modulators of both vascular tone and inflammation. In vascular cognitive impairment (VCI), there is emerging evidence that oxylipins may have both protective and detrimental effects on brain structure, cognitive performance, and disease progression. In this review, we focus on oxylipin relationships with vascular and inflammatory risk factors in human studies and animal models pertinent to ADRD. In addition, we discuss future research directions with the potential to impact the trajectory of ADRD risk and disease progression.
Collapse
Affiliation(s)
- Lynne H. Shinto
- Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., CR120, Portland, OR 97239, USA
| | - Jacob Raber
- Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., CR120, Portland, OR 97239, USA
- Departments of Behavioral Neuroscience and Radiation Medicine, Division of Neuroscience, ONPRC, Oregon Health & Science University, Portland, OR 97239, USA
| | - Anusha Mishra
- Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., CR120, Portland, OR 97239, USA
- Jungers Center for Neurosciences Research, Oregon Health & Science University, Portland, OR 97239, USA
| | - Natalie Roese
- Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., CR120, Portland, OR 97239, USA
| | - Lisa C. Silbert
- Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., CR120, Portland, OR 97239, USA
- Veterans Affairs Medical Center, Portland, OR 97239, USA
| |
Collapse
|
5
|
Gollasch B, Wu G, Liu T, Dogan I, Rothe M, Gollasch M, Luft FC. Hemodialysis and erythrocyte epoxy fatty acids. Physiol Rep 2020; 8:e14601. [PMID: 33112511 PMCID: PMC7592498 DOI: 10.14814/phy2.14601] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 09/13/2020] [Accepted: 09/14/2020] [Indexed: 12/24/2022] Open
Abstract
Fatty acid products derived from cytochromes P450 (CYP) monooxygenase and lipoxygenase (LOX)/CYP ω/(ω-1)-hydroxylase pathways are a superclass of lipid mediators with potent bioactivities. Whether or not the chronic kidney disease (CKD) and hemodialysis treatments performed on end-stage renal disease (ESRD) patients affect RBC epoxy fatty acids profiles remains unknown. Measuring the products solely in plasma is suboptimal. Since such determinations invariably ignore red blood cells (RBCs) that make up 3 kg of the circulating blood. RBCs are potential reservoirs for epoxy fatty acids that regulate cardiovascular function. We studied 15 healthy persons and 15 ESRD patients undergoing regular hemodialysis treatments. We measured epoxides derived from CYP monooxygenase and metabolites derived from LOX/CYP ω/(ω-1)-hydroxylase pathways in RBCs by LC-MS/MS tandem mass spectrometry. Our data demonstrate that various CYP epoxides and LOX/CYP ω/(ω-1)-hydroxylase products are increased in RBCs of ESRD patients, compared to control subjects, including dihydroxyeicosatrienoic acids (DHETs), epoxyeicosatetraenoic acids (EEQs), dihydroxydocosapentaenoic acids (DiHDPAs), and hydroxyeicosatetraenoic acids (HETEs). Hemodialysis treatment did not affect the majority of those metabolites. Nevertheless, we detected more pronounced changes in free metabolite levels in RBCs after dialysis, as compared with the total RBC compartment. These findings indicate that free RBC eicosanoids should be considered more dynamic or vulnerable in CKD.
Collapse
Affiliation(s)
- Benjamin Gollasch
- Experimental and Clinical Research Center (ECRC)A Joint Institution Between the Charité University Medicine and Max Delbrück Center (MDC) for Molecular MedicineBerlin‐BuchGermany
- HELIOS Klinikum Berlin‐BuchBerlinGermany
| | - Guanlin Wu
- Experimental and Clinical Research Center (ECRC)A Joint Institution Between the Charité University Medicine and Max Delbrück Center (MDC) for Molecular MedicineBerlin‐BuchGermany
- Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz AssociationBerlinGermany
| | - Tong Liu
- Experimental and Clinical Research Center (ECRC)A Joint Institution Between the Charité University Medicine and Max Delbrück Center (MDC) for Molecular MedicineBerlin‐BuchGermany
| | | | | | - Maik Gollasch
- Experimental and Clinical Research Center (ECRC)A Joint Institution Between the Charité University Medicine and Max Delbrück Center (MDC) for Molecular MedicineBerlin‐BuchGermany
- Nephrology/Intensive Care SectionCharité Campus VirchowBerlinGermany
- Department of Internal and Geriatric MedicineUniversity Medicine GreifswaldGreifswaldGermany
| | - Friedrich C. Luft
- Nephrology/Intensive Care SectionCharité Campus VirchowBerlinGermany
| |
Collapse
|
6
|
Morris JK, Piccolo BD, John CS, Green ZD, Thyfault JP, Adams SH. Oxylipin Profiling of Alzheimer's Disease in Nondiabetic and Type 2 Diabetic Elderly. Metabolites 2019; 9:metabo9090177. [PMID: 31491971 PMCID: PMC6780570 DOI: 10.3390/metabo9090177] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Revised: 08/27/2019] [Accepted: 09/03/2019] [Indexed: 01/02/2023] Open
Abstract
Oxygenated lipids, called “oxylipins,” serve a variety of important signaling roles within the cell. Oxylipins have been linked to inflammation and vascular function, and blood patterns have been shown to differ in type 2 diabetes (T2D). Because these factors (inflammation, vascular function, diabetes) are also associated with Alzheimer’s disease (AD) risk, we set out to characterize the serum oxylipin profile in elderly and AD subjects to understand if there are shared patterns between AD and T2D. We obtained serum from 126 well-characterized, overnight-fasted elderly individuals who underwent a stringent cognitive evaluation and were determined to be cognitively healthy or AD. Because the oxylipin profile may also be influenced by T2D, we assessed nondiabetic and T2D subjects separately. Within nondiabetic individuals, cognitively healthy subjects had higher levels of the nitrolipid 10-nitrooleate (16.8% higher) compared to AD subjects. AD subjects had higher levels of all four dihydroxyeicosatrienoic acid (DiHETrE) species: 14,15-DiHETrE (18% higher), 11,12 DiHETrE (18% higher), 8,9-DiHETrE (23% higher), and 5,6-DiHETrE (15% higher). Within T2D participants, we observed elevations in 14,15-dihydroxyeicosa-5,8,11-trienoic acid (14,15-DiHETE; 66% higher), 17,18-dihydroxyeicosa-5,8,11,14-tetraenoic acid (17,18-DiHETE; 29% higher) and 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid (17-HDoHE; 105% higher) and summed fatty acid diols (85% higher) in subjects with AD compared to cognitively healthy elderly, with no differences in the DiHETrE species between groups. Although these effects were no longer significant following stringent adjustment for multiple comparisons, the consistent effects on groups of molecules with similar physiological roles, as well as clear differences in the AD-related profiles within nondiabetic and T2D individuals, warrant further research into these molecules in the context of AD.
Collapse
Affiliation(s)
- Jill K Morris
- Department of Neurology, University of Kansas Alzheimer's Disease Center, Kansas City, KS 66205, USA.
- University of Kansas Alzheimer's Disease Center, Fairway, KS 66205, USA.
| | - Brian D Piccolo
- Arkansas Children's Nutrition Center, Little Rock, AR 72205, USA.
- Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
| | - Casey S John
- Department of Neurology, University of Kansas Alzheimer's Disease Center, Kansas City, KS 66205, USA.
- University of Kansas Alzheimer's Disease Center, Fairway, KS 66205, USA.
| | - Zachary D Green
- University of Kansas Alzheimer's Disease Center, Fairway, KS 66205, USA.
| | - John P Thyfault
- Department of Molecular and Integrative Physiology, University of Kansas, Kansas City, KS 66045, USA.
- Kansas City VA Medical Center, Kansas City, MO 64128, USA.
| | - Sean H Adams
- Arkansas Children's Nutrition Center, Little Rock, AR 72205, USA.
- Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
| |
Collapse
|
7
|
Li Y, Lin N, Xu J, Lu Y, Chen S, Pan C, Wang C, Xu M, Zhou B, Xu R, Xu YJ. Measurement of Serum and Hepatic Eicosanoids by Liquid Chromatography Tandem-Mass Spectrometry (LC-MS/MS) in a Mouse Model of Hepatocellular Carcinoma (HCC) with Delivery of c-Met and Activated β-Catenin by Hepatocyte Hydrodynamic Injection. Med Sci Monit 2018; 24:1670-1679. [PMID: 29560932 PMCID: PMC5877205 DOI: 10.12659/msm.908931] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2018] [Accepted: 03/05/2018] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND Most forms of cancer, including hepatocellular carcinoma (HCC), are associated with varying degrees of chronic inflammation. The association between the expression of eicosanoids, which are bioactive lipid mediators of inflammation, and HCC remains unknown. The aim of this study was to measure serum and hepatic eicosanoids in a mouse model of HCC with the delivery of c-Met and activated b-catenin by hepatocyte hydrodynamic injection. MATERIAL AND METHODS The HCC mouse model, and normal control mice, were used in this study with co-delivery of human c-Met combined with activated β-catenin into hepatocytes through hydrodynamic injection. Liquid chromatography tandem-mass spectrometry (LC-MS/MS) analysis was used to measure serum and hepatic eicosanoid levels. RESULTS The combined activation of c-Met and β-catenin was induced in the HCC mouse model. LC-MS/MS showed that a total of 13 eicosanoids in serum and 12 eicosanoids in liver tissue were significantly increased in the HCC mice, when compared with control mice. CONCLUSIONS In a mouse model of HCC, co-activation of the c-Met and β-catenin signaling pathway resulted in increased levels of serum and hepatic eicosanoids.
Collapse
Affiliation(s)
- Yanjie Li
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Nan Lin
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Jianliang Xu
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Yi Lu
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Shuxian Chen
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Chuzhi Pan
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Chusi Wang
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Mingxing Xu
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Boxuan Zhou
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Ruiyun Xu
- Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China
| | - Yong-Jiang Xu
- School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, P.R. China
| |
Collapse
|
8
|
A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach. Sci Rep 2018; 8:3688. [PMID: 29487344 PMCID: PMC5829193 DOI: 10.1038/s41598-018-22074-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2017] [Accepted: 02/16/2018] [Indexed: 12/31/2022] Open
Abstract
The Chinese medicine Qiliqiangxin (QL) has been shown to have a protective role in heart failure. Here, we explore the underlying working mechanism of the key therapeutic component in QL using a rat model of heart failure. Heart failure after myocardial infarction was induced surgically and confirmed using echocardiography; a separate group of rats underwent sham surgery. The rats with heart failure were randomly assigned to receive QL, the angiotensin-converting enzyme inhibitor benazepril, or placebo groups. Blood samples were collected from the rats at four time points for up to 8 weeks and used for biochemical analysis and mass spectrometry‒based metabolomics profiling. In total, we measured nine well-known biochemical parameters of heart failure and 147 metabolites. In the rats with heart failure, QL significantly improved these biochemical parameters and metabolomics profiles, significantly increasing the cardioprotective parameter angiopoietin-like 4 and significantly lowering inflammation-related oxylipins and lysophosphatidic acids compared to benazepril. Mechanistically, QL may improve outcome in heart failure by controlling inflammatory process and cardiac hypertrophy. Clinical studies should be designed in order to investigate these putative mechanisms in patients.
Collapse
|
9
|
Lukic A, Larssen P, Fauland A, Samuelsson B, Wheelock CE, Gabrielsson S, Radmark O. GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures. FASEB J 2017. [PMID: 28637652 DOI: 10.1096/fj.201700319r] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
M1 and M2 activated macrophages (Mϕs) have different roles in inflammation. Because pathogens may first encounter resting cells, we investigated lipid mediator profiles prior to full activation. Human monocytes were differentiated with granulocyte Mϕ colony-stimulating factor (GM-CSF) or Mϕ colony-stimulating factor (M-CSF), which are known to prime toward M1 or M2 phenotypes, respectively. Lipid mediators released during resting conditions and produced in response to bacterial stimuli (LPS/N-formylmethionyl-leucyl-phenylalanine or peptidoglycan) were quantified by liquid chromatography-mass spectrometry. In resting conditions, both Mϕ phenotypes released primarily proresolving lipid mediators (prostaglandin E2 metabolite, lipoxin A4, and 18-hydroxyeicosapentaenoic acid). A striking shift toward proinflammatory eicosanoids was observed when the same cells were exposed (30 min) to bacterial stimuli: M-CSF Mϕs produced considerably more 5-lipoxygenase products, particularly leukotriene C4, potentially linked to M2 functions in asthma. Prostaglandins were formed by both Mϕ types. In the M-CSF cells, there was also an enhanced release of arachidonic acid and activation of cytosolic phospholipase A2 However, GM-CSF cells expressed higher levels of 5-lipoxygenase and 5-lipoxygenase-activating protein, and in ionophore incubations these cells also produced the highest levels of 5-hydroxyeicosatetraenoic acid. In summary, GM-CSF and M-CSF Mϕs displayed similar proresolving lipid mediator formation in resting conditions but shifted toward different proinflammatory eicosanoids upon bacterial stimuli. This demonstrates that preference for specific eicosanoid pathways is primed by CSFs before full M1/M2 activation.-Lukic, A., Larssen, P., Fauland, A., Samuelsson, B., Wheelock, C. E., Gabrielsson, S., Radmark, O. GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures.
Collapse
Affiliation(s)
- Ana Lukic
- Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Pia Larssen
- Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
| | - Alexander Fauland
- Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Bengt Samuelsson
- Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Craig E Wheelock
- Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Susanne Gabrielsson
- Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
| | - Olof Radmark
- Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden;
| |
Collapse
|
10
|
Zhang A, Sun H, Wang X. Emerging role and recent applications of metabolomics biomarkers in obesity disease research. RSC Adv 2017. [DOI: 10.1039/c6ra28715h] [Citation(s) in RCA: 58] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Metabolomics is a promising approach for the identification of metabolites which serve for early diagnosis, prediction of therapeutic response and prognosis of disease.
Collapse
Affiliation(s)
- Aihua Zhang
- Metabolomics Laboratory
- Sino-America Chinmedomics Technology Collaboration Center
- National TCM Key Laboratory of Serum Pharmacochemistry
- Chinmedomics Research Center of State Administration of TCM
- Department of Pharmaceutical Analysis
| | - Hui Sun
- Metabolomics Laboratory
- Sino-America Chinmedomics Technology Collaboration Center
- National TCM Key Laboratory of Serum Pharmacochemistry
- Chinmedomics Research Center of State Administration of TCM
- Department of Pharmaceutical Analysis
| | - Xijun Wang
- Metabolomics Laboratory
- Sino-America Chinmedomics Technology Collaboration Center
- National TCM Key Laboratory of Serum Pharmacochemistry
- Chinmedomics Research Center of State Administration of TCM
- Department of Pharmaceutical Analysis
| |
Collapse
|